Anticoagulation and Thrombin Inhibition in Cardiac Surgery: Blood Management Perspective (EP Video)
Mark T. Lucas discusses the processes of anticoagulation and thrombin inhibition in cardiac surgery (44:48 minutes).
TEG Monitoring of Hemostasis (EP Video)
Mike Miller provides a general overview of TEG monitoring for Hemostasis (30:36 minutes).
Electronic Enhancements for Recipient Safety (EP Video)
Dr. Mark Harris Yazer discusses the new electronic systems used to enhance recipient safety (35:11 minutes).
Thromboelastography and the Management of Coagulopathy During Cardiopulmonary Bypass (EP Video)
Dr. Timothy H. Pohlman discusses the use of the TEG for management of coagulopathy during CPB (38:12 minutes).
TEG Monitoring of Hemostasis (EP Video)
Mike Miller provides a general overview of TEG monitoring for Hemostasis (30:36 minutes).
Massive Transfusion: Protocols, Guidelines and Outcomes: What Works? (EP Video)
Dr. Lena M. Napolitano expands on massive transfusion protocols in an effort hone in the most effective strategies (33:02 minutes).
Massive Transfusion of Blood Components: Ratio-Targeted vs. Goal-Directed Protocols (EP Video)
Dr. Timothy H. Pohlman discusses massive transfusion protocols and goals (32:29 minutes).
Massive Transfusion: Protocols, Guidelines and Outcomes: What Works? (EP Video)
Dr. Lena M. Napolitano expands on massive transfusion protocols in an effort hone in the most effective strategies (33:02 minutes).
The Coagulopathy of Trauma (EP Video)
Dr. Mark Walsh provides insight on coagulopathies associated with trauma surgery (31:52 minutes).
The Effects of Preoperative Renin-Angiotensin System Inhibitors on Outcomes in Patients undergoing Cardiac Surgery
The results suggested that pre-op RAS inhibitor therapy was associated with significant reductions in the risk of AKI, operative mortality, and septicemia.
Blood Loss, Predictors of Bleeding, Transfusion Practice and Strategies of Blood Cell Salvaging during Liver Transplantation
The impact of blood transfusion has been shown to be significant and independent of other well-known predictors of posttransplant-outcome.
Comparison of 30-day Outcomes of Coronary Artery Bypass Grafting Surgery versus Hybrid Coronary Revascularization Stratified by SYNTAX and EuroSCORE
The optimal treatment of multivessel coronary artery disease is not well established.